Leadership Overview
Industrial Technology Research Institute has 8 executives leading key functions including strategy, research oversight, technology development, and human capital management.
Focused on advancing global innovation, Industrial Technology Research Institute drives the 2030 Technology Strategy & Roadmap to transform industries through smart living, quality health, and sustainable environment solutions.
Focused on advancing global innovation, Industrial Technology Research Institute drives the 2030 Technology Strategy & Roadmap to transform industries through smart living, quality health, and sustainable environment solutions.
Leadership Roles at Industrial Technology Research Institute
James Etro - Chief Executive Officer
James Etro, the Chief Executive Officer at Industrial Technology Research Institute, directs the overarching strategic vision for global R&D initiatives. By aligning internal research capabilities with the 2030 Technology Strategy & Roadmap, Etro ensures the institution maintains a competitive edge in smart living and quality health sectors. This leadership role involves managing complex cross-border collaborations across the U.S., Europe, and Japan to expand the reach of proprietary technologies. James Etro monitors the incubation of high-potential startups, fostering an ecosystem that mirrors the success of historical spinoffs. Through rigorous oversight of resource allocation, the Chief Executive Officer optimizes operational efficiency across all research divisions. Etro maintains constant communication with the Board to refine long-term objectives, ensuring that every project contributes to the broader mission of transforming labor-intensive industries into innovation-driven powerhouses. This executive focus secures the institution's position as a premier global technology leader.
Ming-Kai Tsai - Chairman & Chief Executive Officer
Ming-Kai Tsai, the Chairman & Chief Executive Officer at Industrial Technology Research Institute, governs the institutional framework and high-level corporate governance. Overseeing the integration of intelligentization enabling technology, Tsai directs the strategic expansion of R&D scope to address emerging global market trends. This leadership position requires balancing the needs of diverse stakeholders while maintaining the core mission of sustainable environmental development. Ming-Kai Tsai evaluates the performance of major research programs, ensuring alignment with the 2030 Technology Strategy & Roadmap. By fostering international cooperation, the Chairman & Chief Executive Officer strengthens the institution's presence in key global markets. Tsai manages the transition of advanced research into commercial applications, supporting the growth of the broader industrial ecosystem. Through decisive leadership, the Chairman & Chief Executive Officer ensures that all institutional activities promote long-term societal benefits and technological advancement, solidifying the reputation of the organization as a cornerstone of industrial innovation.
Edwin Liu - President
Edwin Liu, the President at Industrial Technology Research Institute, manages the day-to-day operations and ensures the effective execution of the institution's strategic objectives. By coordinating the activities of various research divisions, Liu ensures that all projects remain aligned with the 2030 Technology Strategy & Roadmap. This leadership role involves overseeing the operational integration of smart living, quality health, and sustainable environment initiatives. Edwin Liu facilitates communication between the executive team and the broader organization, ensuring that the mission of transforming industries is clearly understood and pursued. The President monitors the financial and operational performance of the institution, implementing improvements to increase efficiency and impact. By fostering a collaborative environment, Liu supports the development of new technologies and the successful spinoff of innovative startups. This executive function is critical for maintaining the institution's operational excellence, as the President drives the daily progress required to achieve long-term technological and societal goals.
Min-Yuan Chou - Chief Technology Officer
Min-Yuan Chou, the Chief Technology Officer at Industrial Technology Research Institute, directs the technical roadmap and innovation strategy for the entire institution. By overseeing the advancement of intelligentization enabling technology, Chou ensures that all research divisions utilize cutting-edge tools to solve complex industrial problems. This leadership role involves evaluating emerging technologies and determining their potential for long-term integration into the 2030 Technology Strategy & Roadmap. Min-Yuan Chou facilitates collaboration between technical teams, fostering an environment of continuous improvement and cross-disciplinary innovation. The Chief Technology Officer monitors the quality of research outputs, ensuring that all developments meet rigorous scientific standards. By providing technical guidance to the executive team, Chou supports the successful incubation of new startups and spinoffs. This role is essential for maintaining the institution's status as a global leader in R&D, as the Chief Technology Officer drives the technical excellence required to transform industries and address global market trends.
Guang- Way Jang - Deputy Director
Guang- Way Jang, the Deputy Director at Industrial Technology Research Institute, manages the operational execution of smart living technology projects. By coordinating cross-functional teams, Jang accelerates the development of scalable solutions that address modern societal needs. This role involves translating complex research findings into actionable industrial applications, specifically focusing on the integration of intelligentization enabling technology. Guang- Way Jang monitors project milestones to ensure adherence to the 2030 Technology Strategy & Roadmap, providing critical support to senior leadership during the commercialization phase. The Deputy Director facilitates knowledge transfer between research labs and external partners, enhancing the overall impact of the institution's R&D efforts. Through meticulous oversight of technical resources, Jang optimizes the development lifecycle of new products. This leadership function directly supports the institutional goal of driving innovation-led growth, ensuring that every project meets the highest standards of quality and market relevance within the competitive global landscape.
Henry Mao - Deputy Director
Henry Mao, the Deputy Director at Industrial Technology Research Institute, oversees the strategic development of quality health technologies. By directing research teams focused on medical and wellness innovations, Mao ensures that the institution remains at the forefront of the healthcare technology sector. This leadership role involves managing the transition of laboratory prototypes into viable market solutions, thereby supporting the broader 2030 Technology Strategy & Roadmap. Henry Mao coordinates with international branch offices to leverage global expertise, enhancing the efficacy of health-related R&D initiatives. The Deputy Director evaluates the technical feasibility of new projects, ensuring that all developments align with the core mission of improving societal well-being. Through consistent monitoring of project outcomes, Mao optimizes the allocation of research funding and personnel. This executive focus on health innovation strengthens the institution's portfolio, providing essential support for the advancement of sustainable and intelligent healthcare systems across diverse global markets.
Ching Ting - Deputy Director
Ching Ting, the Deputy Director at Industrial Technology Research Institute, leads the development of sustainable environment technologies. By architecting research frameworks that prioritize energy efficiency and ecological preservation, Ting ensures that the institution contributes meaningfully to global sustainability goals. This role involves managing the integration of intelligentization enabling technology into environmental monitoring systems, providing robust solutions for modern industrial challenges. Ching Ting coordinates with internal departments to streamline the R&D process, ensuring that sustainable innovations reach the market with maximum impact. The Deputy Director monitors the progress of key environmental projects, aligning all activities with the 2030 Technology Strategy & Roadmap. Through strategic partnerships with global entities, Ting expands the reach of these green technologies, fostering international cooperation. This leadership function supports the institutional commitment to creating a better future for society, ensuring that environmental sustainability remains a central pillar of the organization's ongoing technological research and development efforts.
Wen-ting Hsueh - 人力資源管理
Wen-ting Hsueh, the 人力資源管理 at Industrial Technology Research Institute, directs the human capital strategy to support the institution's ambitious R&D goals. By managing talent acquisition and professional development programs, Hsueh ensures that the organization attracts and retains the brightest minds in the technology sector. This leadership role involves aligning workforce capabilities with the 2030 Technology Strategy & Roadmap, fostering a culture of innovation and excellence. Wen-ting Hsueh oversees the implementation of training initiatives that enhance technical and leadership skills across all departments. The 人力資源管理 monitors organizational health and employee engagement, ensuring that the internal environment supports the high-pressure demands of global research. By optimizing human resource processes, Hsueh facilitates the seamless operation of branch offices in the U.S., Europe, and Japan. This executive focus on human capital is vital for the institution's success, as the 人力資源管理 builds the foundation of expertise necessary to drive technological breakthroughs and maintain a competitive edge.
Explore Leadership Teams in Business Services
Syneos Health, founded in 1998, is a global biopharmaceutical research and development services company that provides integrated clinical and commercial solutions. The company operates across more than 110 countries, offering expertise in clinical trials, medical affairs, and commercial strategy to help bring therapies to market faster. Syneos Health leverages advanced technologies and data-driven insights to address modern healthcare challenges and improve patient outcomes. The company serves pharmaceutical, biotechnology, and healthcare organizations worldwide with specialized services including clinical research, consulting, and marketing. Headquartered in the United States with significant operations across Europe, Asia Pacific, Africa, and the Americas, Syneos Health maintains a global presence in the life sciences industry.
Company Leadership
MJ
MB
Founded in 2012, WCG measurably improves the quality and efficiency of clinical trials, helping biopharmaceutical companies, CROs, and institutions facilitate the development of new treatments and therapies for patients. The company is headquartered in Princeton, New Jersey.
Company Leadership CC

PM
Founded in 2000 by the Government of the Hong Kong SAR, ASTRI aims to enhance Hong Kong's competitiveness in technology-based industries through applied research. The institute specializes in various technology divisions, including Smart City, Financial Technologies, and Digital Health, and has transferred around 1,600 technologies to the industry. ASTRI nurtures research and innovation talents, holding close to 1,200 patents and receiving numerous international awards for its contributions. Its clients include businesses seeking to leverage technology for improved efficacy and competitive strength.
Company Leadership PL
RO
CP
TS
Founded in 1986, AmSpec is headquartered in Cranbury, New Jersey. They provide inspection and testing services to multiple sectors of the agricultural, oil and petrochemical industries.
Company Leadership
AP
SE
MM